C. trachomatis Antibody (NYRChlam LPS): sc-71464

C. trachomatis Antibody (NYRChlam LPS) is a mouse monoclonal IgG2b antibody that detects Chlamydia trachomatis by enzyme-linked immunosorbent assay (ELISA). C. trachomatis is a significant human pathogen responsible for various diseases, including sexually transmitted infections and trachoma, which can lead to blindness. The major outer membrane protein (MOMP) of C. trachomatis plays a crucial role in the bacterium′s ability to adhere to and invade host cells, making MOMP a key target for diagnostic and therapeutic strategies. MOMP is characterized by a complex structure, which includes multiple transmembrane domains that facilitate function as a porin, allowing the passage of nutrients and waste products across the bacterial membrane. Understanding MOMP structure is vital, as this knowledge aids in developing effective vaccines and enhances anti-C. trachomatis antibody (NYRChlam LPS) specificity in detecting the pathogen in clinical samples. C. trachomatis monoclonal antibody (NYRChlam LPS) provides a reliable means to identify and quantify C. trachomatis infections, contributing to better management and treatment of diseases associated with this bacterium.